Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in
the Western world. Cirrhosis remains the predominant risk factor for HCC. However …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Background The overall value of hepatocellular carcinoma screening is defined by the
balance of benefits and harms. Studies have only reported physical harms with none …

Abdominal US is currently the best-validated surveillance strategy for hepatocellular
carcinoma (HCC) in at-risk patients. It is the only modality shown to have completed all five …

Background & Aims Hepatocellular carcinoma (HCC) surveillance is associated with
improved early detection and reduced mortality, although practice patterns and effectiveness …

Importance The risk of hepatocellular carcinoma (HCC) declines over time after hepatitis C
virus (HCV) cure by direct-acting antiviral (DAA) therapies. Liver society guidelines …

Importance Cohort studies demonstrating an association of hepatocellular carcinoma (HCC)
screening with reduced mortality are prone to lead-time and length-time biases. Objective To …

Introduction: Given suboptimal performance of ultrasound-based surveillance for early
hepatocellular carcinoma (HCC) detection in patients with cirrhosis, there is interest in …

Background The value of hepatocellular carcinoma (HCC) screening is defined by the
balance of benefits from early tumor detection vs harms due to false positive results. We …

Simple Summary Liver cancer ranks as the sixth most common type of cancer and is the
third leading cause of cancer deaths. The most frequent type of liver cancer is hepatocellular …